Zurich Cantonal Bank
IART icon

Zurich Cantonal Bank’s Integra LifeSciences IART Stock Holding History

Zurich Cantonal Bank’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,014
Closed -$236K – 3003
2025
Q4 		$236K Buy
+19,014
New +$253K ﹤0.01% 2168

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's IART Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Integra LifeSciences (IART) in Q1 2026: 28,785 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #2139 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IART as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in IART in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.61M in Q3 2013. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Zurich Cantonal Bank held 28,785 shares of Integra LifeSciences worth $271K as of Q1 2026.
  • Integra LifeSciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2139 holding.
  • Zurich Cantonal Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 46 quarters since.
  • Zurich Cantonal Bank's Integra LifeSciences position peaked at $1.61M in Q3 2013.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.